Oklahoma City biotech company releases step-by-step mycoplasma detection and elimination protocol
OKLAHOMA CITY - OklaNews -- OKLAHOMA CITY, OK — PurMa Biologics, a leading manufacturer of cell culture reagents and biologics services, has published a comprehensive mycoplasma detection and elimination protocol available free to the scientific community via protocols.io.
Mycoplasma contamination is estimated to affect up to 35% of cell cultures worldwide, making it one of the most significant threats to research reproducibility and integrity. Left undetected, mycoplasma can alter cell behavior, gene expression, and experimental results, leading to costly research failures.
The protocol, developed by PurMa Biologics' team of scientists with over 30 years of combined expertise in cell culture and protein biochemistry, outlines a clear 5-step process for detecting and eliminating mycoplasma contamination using validated reagents.
"We want to give researchers the tools and knowledge they need to maintain clean, reliable cell cultures," said Seifollah Azadi, Founder and CEO of PurMa Biologics. "This protocol is part of our commitment to supporting the scientific community beyond just supplying reagents."
More on oklanews.com
PurMa Biologics offers over 3,000 cell culture reagents including culture media, buffers, serums, trypsin, transfection reagents, and mycoplasma detection and elimination kits. The company also provides custom biotech services including monoclonal antibody development, protein expression and purification, and gene cloning.
The free protocol is available at: http://www.protocols.io/workspaces/purma-biologics
For more information about PurMa Biologics and their full catalog of cell culture reagents, visit http://www.purmabiologics.com or call 1-866-720-6116.
About PurMa Biologics:
PurMa Biologics is an Oklahoma City-based biotechnology company specializing in cell culture reagents and biologics services. With over 30 years of combined expertise, PurMa Biologics serves research institutions, biotechnology companies, and laboratories worldwide with 3,000+ high-quality reagents and custom research services.
Mycoplasma contamination is estimated to affect up to 35% of cell cultures worldwide, making it one of the most significant threats to research reproducibility and integrity. Left undetected, mycoplasma can alter cell behavior, gene expression, and experimental results, leading to costly research failures.
The protocol, developed by PurMa Biologics' team of scientists with over 30 years of combined expertise in cell culture and protein biochemistry, outlines a clear 5-step process for detecting and eliminating mycoplasma contamination using validated reagents.
"We want to give researchers the tools and knowledge they need to maintain clean, reliable cell cultures," said Seifollah Azadi, Founder and CEO of PurMa Biologics. "This protocol is part of our commitment to supporting the scientific community beyond just supplying reagents."
More on oklanews.com
- Dentistry By Design's Dr. Edward Harroz Advances Full-Arch Implant Expertise
- Stu Starr Returns to the Dance Floor with I'm A Star: The Remixes
PurMa Biologics offers over 3,000 cell culture reagents including culture media, buffers, serums, trypsin, transfection reagents, and mycoplasma detection and elimination kits. The company also provides custom biotech services including monoclonal antibody development, protein expression and purification, and gene cloning.
The free protocol is available at: http://www.protocols.io/workspaces/purma-biologics
For more information about PurMa Biologics and their full catalog of cell culture reagents, visit http://www.purmabiologics.com or call 1-866-720-6116.
About PurMa Biologics:
PurMa Biologics is an Oklahoma City-based biotechnology company specializing in cell culture reagents and biologics services. With over 30 years of combined expertise, PurMa Biologics serves research institutions, biotechnology companies, and laboratories worldwide with 3,000+ high-quality reagents and custom research services.
Source: PurMa Biologics
0 Comments